Prognostic implications of increased cardiac biomarkers and ST segment depression in non-ST elevation acute coronary syndromes: lessons from the acute coronary syndrome Israeli survey (ACSIS) 2002.

The impact of inflammatory rheumatic diseases on the presentation, severity, and outcome of acute coronary syndrome. Clin Rheumatol (2014) 0.75

Trends in the management and outcomes of patients admitted with acute coronary syndrome complicated by cardiogenic shock over the past decade: Real world data from the acute coronary syndrome Israeli survey (ACSIS). Oncotarget (2017) 0.75

Impact of the troponin standard on the prevalence of acute myocardial infarction. Am Heart J (2003) 2.02

Sources of diagnostic inaccuracy of conventional versus new diagnostic criteria for myocardial infarction in an unselected UK population with suspected cardiac chest pain, and investigation of independent prognostic variables. Heart (2003) 1.19

Troponin is more useful than creatine kinase in predicting one-year mortality among acute coronary syndrome patients. Eur Heart J (2004) 1.04

The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature (1997) 13.09

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA (2000) 5.49

A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J (2002) 4.15

Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy. Am J Cardiol (1995) 2.98

Researchers deny any attempt to mislead the public over JAMA article on arthritis drug. BMJ (2001) 2.94

Use of pulmonary artery catheters in patients with acute myocardial infarction. Analysis of experience in 5,841 patients in the SPRINT Registry. SPRINT Study Group. Chest (1990) 2.89

Controversy over new editor at New England Journal of Medicine. BMJ (2000) 2.58

Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study. Arch Intern Med (1993) 2.43

In-hospital and 1-year mortality in 1,524 women after myocardial infarction. Comparison with 4,315 men. Circulation (1991) 2.13

Increased mean platelet volume is associated with non-responsiveness to clopidogrel. Thromb Haemost (2014) 2.04

Sex differences in management and outcome after acute myocardial infarction in the 1990s: A prospective observational community-based study. Israeli Thrombolytic Survey Group. Circulation (2000) 2.02

Long-term mortality follow-up of hospital survivors of a myocardial infarction randomized to nifedipine in the SPRINT study. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Cardiovasc Drugs Ther (1998) 2.01

Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads V7-9: "hidden" ST-segment elevations revealing acute posterior infarction. J Am Coll Cardiol (1999) 2.00

Is the FDA approving drugs too fast?. Probably not--but drug recalls have sparked debate. BMJ (1998) 1.95

Disappearance of a syndrome: Dressler's syndrome in the era of thrombolysis. Cardiology (1994) 1.91

The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: a mechanism for T helper cell type 1-mediated damage. J Exp Med (1998) 1.86

Treatment of torsade de pointes with magnesium sulfate. Circulation (1988) 1.84

Population-based analysis of the effect of the Northridge Earthquake on cardiac death in Los Angeles County, California. J Am Coll Cardiol (1997) 1.79

Significance of ST segment elevations in posterior chest leads (V7 to V9) in patients with acute inferior myocardial infarction: application for thrombolytic therapy. J Am Coll Cardiol (1998) 1.67

Long-term prognosis of women after myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Am J Epidemiol (1997) 1.62

Natural history of left ventricular thrombi: their appearance and resolution in the posthospitalization period of acute myocardial infarction. J Am Coll Cardiol (1990) 1.61

Cytotoxic T lymphocytes are activated following myocardial infarction and can recognize and kill healthy myocytes in vitro. J Mol Cell Cardiol (2000) 1.60

Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients. Cochrane Database Syst Rev (2004) 1.59

Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study. J Am Coll Cardiol (1990) 1.58

Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up. Cardiology (1999) 1.52

Lack of progress in cardiogenic shock: lessons from the GUSTO trials. Eur Heart J (2000) 1.50

Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. SPRINT and Thrombolytic Survey Groups. Circulation (1998) 1.47

Pindolol-induced tremor. Postgrad Med J (1980) 1.45

Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial). Am J Cardiol (1993) 1.43

Mortality trends in men and women with acute myocardial infarction in coronary care units in Israel. A comparison between 1981-1983 and 1992-1994. For the SPRINT and the Israeli Thrombolytic Survey Groups. Eur Heart J (2000) 1.43

Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease. J Am Coll Cardiol (1999) 1.42

Long-term follow-up of twenty patients with adenocarcinoma of the pancreas: resection following combined modality therapy. Surg Clin North Am (2001) 1.41

Primary ventricular tachycardia in acute myocardial infarction: clinical characteristics and mortality. The SPRINT Study Group. Ann Intern Med (1992) 1.41

Q wave and Non-Q wave myocardial infarction after thrombolysis. J Am Coll Cardiol (1995) 1.41

Calcium antagonists and mortality in patients with coronary artery disease: a cohort study of 11,575 patients. J Am Coll Cardiol (1996) 1.40

Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group. J Am Coll Cardiol (1998) 1.40

States' use of transfer of custody as a requirement for providing services to emotionally disturbed children. Hosp Community Psychiatry (1991) 1.39

Clinical problem-solving. The domino principle. N Engl J Med (1996) 1.38

Does the coronary care unit improve prognosis of patients with acute myocardial infarction? A thrombolytic era study. Eur Heart J (1999) 1.37

Mortality and morbidity rates of patients older and younger than 75 years with acute myocardial infarction treated with intravenous streptokinase. Am J Cardiol (1987) 1.36

Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA (1992) 1.32

The expression of Jagged1 in the developing mammalian heart correlates with cardiovascular disease in Alagille syndrome. Hum Mol Genet (1999) 1.27

Methylphenidate works by increasing dopamine levels. BMJ (2001) 1.25

Relation of coronary artery disease to atherosclerotic disease in the aorta, carotid, and femoral arteries evaluated by ultrasound. Am J Cardiol (1997) 1.25

Mutation analysis of TBX1 in non-deleted patients with features of DGS/VCFS or isolated cardiovascular defects. J Med Genet (2001) 1.24

Echocardiographic diagnosis of aortic valve vegetations in candida endocarditis. Circulation (1974) 1.21

Beneficial effect of magnesium sulfate in acute myocardial infarction. Am J Cardiol (1990) 1.21

Hemodynamic features of prolapsing and nonprolapsing left atrial myxoma. Circulation (1975) 1.20

Gingival hyperplasia caused by nifedipine--a preliminary report. Int J Cardiol (1984) 1.20

Prognostic significance of mild mitral regurgitation by color Doppler echocardiography in acute myocardial infarction. Am J Cardiol (2000) 1.18

Prognostic significance of ischemic episodes in patients with previous myocardial infarction. Am J Cardiol (1988) 1.17

Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome. Circulation (1991) 1.15

Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J Mol Cell Cardiol (2001) 1.14

Apoptosis. Basic concepts and implications in coronary artery disease. Arterioscler Thromb Vasc Biol (1999) 1.13

Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) Registry. Circulation (1999) 1.13

Frequency and distribution of atherosclerotic plaques in the thoracic aorta as determined by transesophageal echocardiography in patients with coronary artery disease. Am J Cardiol (1997) 1.11

Prazosin therapy for refractory variant angina. Am Heart J (1983) 1.10

Impaired fasting glucose concentrations in nondiabetic patients with ischemic heart disease: a marker for a worse prognosis. Am Heart J (2001) 1.09

The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. J Clin Epidemiol (1995) 1.08

Evaluation of electrocardiogram in emergency room as a decision-making tool. Chest (1977) 1.08

Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation, and ventricular function. Circulation (1983) 1.07

Myocardial infarction after vascular surgery: the role of prolonged stress-induced, ST depression-type ischemia. J Am Coll Cardiol (2001) 1.07

Long-term immunity to diphtheria and tetanus: a mathematical model. Am J Epidemiol (1967) 1.05

Predictive value of anatomical findings and karyotype analysis in the diagnosis of patients with disorders of sexual development. Sex Dev (2007) 1.05

Echocardiographic diagnosis of left atrial myxoma. Usefulness of suprasternal approach. Br Heart J (1976) 1.04

Diagnostic laparoscopy: a 5-year experience in a hepatology training program. Am J Gastroenterol (1995) 1.04

The significance of persistent ST elevation versus early resolution of ST segment elevation after primary PTCA. J Am Coll Cardiol (1999) 1.03

IMAGE CARDIO MED: Percutaneous closure of a left ventricular outflow tract pseudoaneurysm causing extrinsic left coronary artery compression by transseptal approach. Circulation (2010) 1.03

Usefulness of a rapid initial increase in plasma creatine kinase activity as a marker of reperfusion during thrombolytic therapy for acute myocardial infarction. Am J Cardiol (1988) 1.03

Avoidance of immune response prolongs expression of genes delivered to the adult rat myocardium by replication-defective adenovirus. Circulation (1996) 1.03

Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement. Circulation (1999) 1.03

Effect of hyperglycemia on pain perception and on efficacy of morphine analgesia in rats. Diabetes (1988) 1.02

Disposition of presumed coronary patients from an emergency room. A follow-up study. JAMA (1976) 1.02

Enzymatic Decomposition of Lignin. Science (1949) 1.02

Gap in HIV infection widens. BMJ (1998) 1.01

Breast artery calcium on routine mammography as a potential marker for increased risk of cardiovascular disease. Am J Cardiol (2000) 1.01

Characterization of 10p deletions suggests two nonoverlapping regions contribute to the DiGeorge syndrome phenotype. Am J Hum Genet (1998) 1.01

Scar thinning due to ibuprofen administration after experimental myocardial infarction. Am J Cardiol (1983) 1.01

Early atrial fibrillation during evolving myocardial infarction: a consequence of impaired left atrial perfusion. Circulation (1987) 1.01

Improved outcome of elderly patients (> or = 75 years of age) with acute myocardial infarction from 1981-1983 to 1992-1994 in Israel. The SPRINT and Thrombolytic Survey Groups. Secondary Prevention Reinfarction Israel Nifedipine Trial. Circulation (1997) 1.00

A novel cell surface antigen (T305) found in increased frequency on acute leukemia cells and in autoimmune disease states. J Immunol (1983) 1.00

Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial. Am Heart J (2001) 0.99

Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. SPRINT Study Group. Am J Med (1993) 0.99

Relation of early and one-year outcome after acute myocardial infarction to systemic arterial blood pressure on admission. Am J Cardiol (1999) 0.99

Thrombolysis in the presence of an intracranial meningioma. Chest (1997) 0.99

Cardiovascular risk factors and clinical presentation in acute coronary syndromes. Heart (2005) 0.99

Male hypogonadism: an extended classification based on a developmental, endocrine physiology-based approach. Andrology (2012) 0.98

Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group. Am J Cardiol (1996) 0.97

Complete atrioventricular block complicating inferior acute wall myocardial infarction: short- and long-term prognosis. Am Heart J (1993) 0.97

Ventricular fibrillation caused by myocardial reperfusion in Prinzmetal's angina. Am Heart J (1983) 0.97

Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial Infarction. Br Heart J (1990) 0.97

Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study Group. Arterioscler Thromb Vasc Biol (1996) 0.96